Samantha E Jacobs
Overview
Explore the profile of Samantha E Jacobs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
732
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baneman E, Weinberg A, Sullivan T, Fuller R, Dunn D, Taimur S, et al.
Transpl Infect Dis
. 2025 Jan;
e14439.
PMID: 39826147
Background: Although infections are a leading cause of morbidity and mortality among patients with multiple myeloma (MM), the epidemiology of invasive fungal disease (IFD) is less well characterized in this...
2.
Jacobs S, Chaturvedi V
Open Forum Infect Dis
. 2024 Nov;
11(11):ofae646.
PMID: 39544494
The global burden of invasive fungal disease is substantial and escalating. Combination antifungal therapy (CAF) may improve patient outcomes by reducing development of resistance, improving drug penetration and rate of...
3.
Jacobs S, Ibrahim U, Barreto Vega A, Lagdameo J, Callahan J, Govindarajulu U, et al.
Transpl Infect Dis
. 2024 May;
26(3):e14290.
PMID: 38708941
Background: Cytomegalovirus-specific T-cell-mediated immunity (CMV-CMI) protects from CMV infection in allogeneic hematopoietic cell transplantation (allo-HCT), but to date, there is no validated measure of CMV immunity for this population. Methods:...
4.
Alahmdi B, Kaur A, Jacobs S, Sullivan T, Barghash M, Taimur S
Open Forum Infect Dis
. 2024 Jan;
11(1):ofad698.
PMID: 38264096
https://tidbitapp.io/tidbits/trypanosoma-cruzi-reactivation-post-chimeric-antigen-receptor-t-cell-therapy/update.
5.
Fuller R, Jacobs S
Mycopathologia
. 2023 Jun;
188(6):893-905.
PMID: 37277679
Intravascular diseases due to Candida species, including endocarditis and cardiac device-associated infections, are rare yet devastating manifestations of invasive candidiasis affecting an already vulnerable population. Despite their significant associated morbidity...
6.
Jacobs S, Walsh T
J Fungi (Basel)
. 2023 Feb;
9(2).
PMID: 36836326
The incidence of invasive sino-pulmonary diseases due to non- hyaline molds is increasing due to an enlarging and evolving population of immunosuppressed hosts as well as improvements in the capabilities...
7.
Caro J, Madero-Marroquin R, Zubizarreta N, Moshier E, Tremblay D, Coltoff A, et al.
Clin Lymphoma Myeloma Leuk
. 2022 Sep;
22(12):903-911.
PMID: 36109322
Introduction: Fluoroquinolone prophylaxis is recommended during induction chemotherapy for patients with acute myeloid leukemia (AML) to reduce risk of neutropenic fever and systemic bacterial infections. We evaluated the effectiveness of...
8.
Jacobs S, Jacobs J, Dennis E, Taimur S, Rana M, Patel D, et al.
Antimicrob Agents Chemother
. 2022 Jun;
66(7):e0005322.
PMID: 35770999
Candida auris is an urgent antimicrobial resistance threat due to its global emergence, high mortality, and persistent transmissions. Nearly half of C. auris clinical and surveillance cases in the United...
9.
McKay F, Spiteri S, Zinga J, Sulemani K, Jacobs S, Ranjan N, et al.
Curr Nutr Rep
. 2022 May;
11(3):486-499.
PMID: 35501553
Purpose Of The Review: Food insecurity can have a negative health impact for women during pregnancy and the postpartum period; however, there are a range of barriers to meeting nutritional...
10.
Jacobs S, Zagaliotis P, Walsh T
F1000Res
. 2022 Feb;
10:507.
PMID: 35136573
Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance,...